Loading
Latest filing published 15 Sept 2026 for Ultragenyx Pharmaceutical Inc., €15k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
One trade, one date: on 15 September 2026, Theodore Huizenga disclosed a transaction of €15k in Ultragenyx Pharmaceutical Inc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration